Total Equity - Design Therapeutics Inc (NASDAQ:DSGN) - Alpha Spread

Watchlist Manager

Watchlist

Price: 4.47 USD 1.36%

Updated:

Design Therapeutics Inc
Total Equity

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

|

Adjust for Inflation

Design Therapeutics Inc
Total Equity Peer Comparison

ABBV

GILD

AMGN

VRTX

REGN

Company		Total Equity	CAGR 3Y	CAGR 5Y	CAGR 10Y
	Design Therapeutics Inc NASDAQ:DSGN	Total Equity $277.7m	CAGR 3-Years 101%	CAGR 5-Years N/A	CAGR 10-Years N/A
	Abbvie Inc NYSE:ABBV	Total Equity $8B	CAGR 3-Years -16%	CAGR 5-Years N/A	CAGR 10-Years 5%
	Gilead Sciences Inc NASDAQ:GILD	Total Equity $17.5B	CAGR 3-Years -3%	CAGR 5-Years -4%	CAGR 10-Years 3%
	Amgen Inc NASDAQ:AMGN	Total Equity $5B	CAGR 3-Years -19%	CAGR 5-Years -14%	CAGR 10-Years -14%
	Vertex Pharmaceuticals Inc NASDAQ:VRTX	Total Equity $18.5B	CAGR 3-Years 27%	CAGR 5-Years 31%	CAGR 10-Years 31%
	Regeneron Pharmaceuticals Inc NASDAQ:REGN	Total Equity $27B	CAGR 3-Years 31%	CAGR 5-Years 23%	CAGR 10-Years 28%

See Also

Based on the financial report for Dec 31, 2023, Design Therapeutics Inc's Total Equity amounts to 277.7m USD.

Over the last year, the Total Equity growth was -15%. The average annual Total Equity growth rates for Design Therapeutics Inc have been 101% over the past three years .

Join more than 139,000+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.